Merck (NYSE:MRK) shares took a slight hit today on fourth-quarter results that came up shy of the consensus forecast.
Additionally, the company announced that chairman & CEO Kenneth C. Frazier will retire, effective June 30, 2021, and he will continue to serve on Merck’s board of directors as executive chairman for a transition period to be determined by the board.
Robert M. Davis, currently Merck’s executive VP of global services & CFO, has been unanimously elected by the board to assume the role of CEO, effective July 1, 2021. He will become president of Merck, effective April 1, 2021.
“The board and I are delighted that Rob will serve as Merck’s next CEO,” Frazier said in a news release. “He has deep knowledge of our company and industry and has been a valued strategic thought partner to me and the Merck senior management team as well as a highly capable finance leader.
“Rob has been instrumental in helping Merck take …